January 2017 PMID 26852373

Nutraceuticals with a clinically detectable blood pressure-lowering effect: a review of available randomized clinical trials and their meta-analyses.

Claudio Borghi, Arrigo F G Cicero

Download social card

Mentions

Peak: 2 in Nov 2025

across 4 sources since May 2020

Extended reach

85,670

potential audience

Total likes

345

Video views

83,385

Mentions per month

May 2020 – Nov 2025

Where it's discussed

News5 articles
YouTube3 videos
Facebook2 posts
X / Twitter1 posts

AI synopsis

What people are saying

Discussions highlight the importance of the study by referencing how some nutraceuticals, such as magnesium and garlic, could be integrated into hypertension management, with comments like 'this could change how we approach treatment' and 'more research is needed.' The tone and choice of words suggest a keen interest in the clinical relevance and future implications of the research.

AgreementModerate agreement

Most discussions suggest alignment with the article's findings that certain nutraceuticals can lower blood pressure, using positive language like 'support' and 'promising evidence'.

InterestHigh interest

Comments demonstrate a high level of curiosity about practical applications, mentioning diet and supplements, indicating strong interest.

EngagementModerate engagement

Posts delve into details, discussing specific nutraceuticals, safety profiles, and clinical implications, showing moderate engagement.

ImpactModerate impact

Participants recognize the potential for these findings to influence future research and clinical practices, reflecting a moderate perceived impact.

Abstract in brief

The study reviewed randomized clinical trials and meta-analyses published between 1990 and 2015 to evaluate the blood pressure-lowering effects of various nutraceuticals, including dietary supplements like potassium, magnesium, L-arginine, vitamin C, cocoa flavonoids, beetroot juice, coenzyme Q10, melatonin, and aged garlic extract.
Most evidence supports that these nutraceuticals have a dose-dependent blood pressure reducing effect and generally have high tolerability and safety profiles, similar to well-known dietary approaches like the DASH and Mediterranean diets.
The authors conclude that some nutraceuticals may positively impact blood pressure, but more clinical research is needed to determine which are most cost-effective, safe, and beneficial for long-term use in individuals with uncomplicated hypertension.

Read the full abstract